authors
- Jasas, KV
- Fyles, A
- Elit, Laurie
- Hoskins, PJ
- Biagi, J
- Dubuc-Lissoir, J
- Matthews, S
- Dancey, J
- Eisenhauer, E
- Oza, AM
Phase II study of erlotinib (OSI 774) in women with recurrent or metastatic endometrial cancer: NCICCTG IND-148.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- July 15, 2004
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal